Dr. Andreas S. Barth is an Associate Professor in the Division of Cardiology at the Johns Hopkins School of Medicine and the Medical Director of the Center for Inherited Heart Diseases. His clinical work focuses on clinical cardiac electrophysiology with a specific focus on inherited arrhythmia syndromes and channelopathies, including long QT syndrome, Brugada syndrome, CPVT, and arrhythmogenic cardiomyopathies. Additionally, Dr. Barth participates in a multidisciplinary clinic at Kennedy Krieger Institute providing cardiology care to patients with muscular dystrophies and mitochondrial disease. Dr. Barth performs pacemaker and defibrillator implantation and complex catheter ablations for atrial and ventricular arrhythmias. His research laboratory focuses on identifying biomarkers of sudden cardiac death and defining the relationship between mitochondrial dysfunction and arrhythmias. In addition, he conducts clinical research for patients with genetic heart disease. Within the Johns Hopkins Center for Inherited Heart Diseases, Dr. Barth serves as the site principal investigator for two cardiac gene therapy trials in PKP2-associated arrhythmogenic right ventricular cardiomyopathy, and he participates in clinical drug trials in PRKAG2 cardiomyopathy, arrhythmogenic cardiomyopathies, and congenital long QT syndrome, advancing personalized medicine approaches for inherited cardiac diseases. Dr. Barth earned a combined doctor of medicine and doctor of philosophy degree from the Ludwig-Maximilians-University in Munich, Germany. He joined the Johns Hopkins faculty in 2016.